{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:19:59Z","timestamp":1792696799744,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01408-x","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:35:25Z","timestamp":1782228925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["BASP1 promotes breast cancer progression and shapes an immunosuppressive microenvironment by recruiting MDSCs and suppressing T cell function"],"prefix":"10.1007","volume":"39","author":[{"given":"Haijie","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi\u2019an","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuzhong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuegang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"1408_CR1","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2020.5771","author":"L Qian","year":"2020","unstructured":"Qian L, Fei Q, Zhang H, Qiu M, Zhang B, Wang Q, et al. lncRNA HOTAIR promotes DNA repair and radioresistance of breast cancer via EZH2. DNA Cell Biol. 2020. https:\/\/doi.org\/10.1089\/dna.2020.5771.","journal-title":"DNA Cell Biol"},{"issue":"5","key":"1408_CR2","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1158\/1078-0432.CCR-07-4077","volume":"14","author":"Y Huang","year":"2008","unstructured":"Huang Y, Anderson KE, Nagamani M, Grady JJ, Lu LJ. Dietary intake of lactose as a strong predictor for secretor status of nipple aspirate fluid in healthy premenopausal nonlactating women. Clin Cancer Res. 2008;14(5):1386\u201392. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4077.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1408_CR3","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2022","unstructured":"Filho AM, Laversanne M, Ferlay J, Colombet M, Pineros M, Znaor A, et al. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2022;156(7):1336\u201346. https:\/\/doi.org\/10.1002\/ijc.35278.","journal-title":"Int J Cancer"},{"issue":"27","key":"1408_CR4","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1038\/s41388-023-02731-5","volume":"42","author":"L Li","year":"2023","unstructured":"Li L, Wang X, Hu K, Liu X, Qiu L, Bai C, et al. ZNF133 is a potent suppressor in breast carcinogenesis through dampening L1CAM, a driver for tumor progression. Oncogene. 2023;42(27):2166\u201382. https:\/\/doi.org\/10.1038\/s41388-023-02731-5.","journal-title":"Oncogene"},{"issue":"7","key":"1408_CR5","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1111\/cas.15373","volume":"113","author":"M Fukuoka","year":"2022","unstructured":"Fukuoka M, Ichikawa Y, Osako T, Fujita T, Baba S, Takeuchi K, et al. The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer. Cancer Sci. 2022;113(7):2336\u201351. https:\/\/doi.org\/10.1111\/cas.15373.","journal-title":"Cancer Sci"},{"issue":"1","key":"1408_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng LW, Ding Y, Chen YF, Cai YW, Wang LP, et al. Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther. 2025;10(1):49. https:\/\/doi.org\/10.1038\/s41392-024-02108-4.","journal-title":"Signal Transduct Target Ther"},{"key":"1408_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920940928","volume":"12","author":"Y Zou","year":"2020","unstructured":"Zou Y, Zou X, Zheng S, Tang H, Zhang L, Liu P, et al. Efficacy and predictive factors of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis. Ther Adv Med Oncol. 2020;12:1758835920940928. https:\/\/doi.org\/10.1177\/1758835920940928.","journal-title":"Ther Adv Med Oncol"},{"key":"1408_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.991797","volume":"13","author":"J Yang","year":"2022","unstructured":"Yang J, Xu Y, Xie K, Gao L, Zhong W, Liu X. CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma. Front Immunol. 2022;13:991797. https:\/\/doi.org\/10.3389\/fimmu.2022.991797.","journal-title":"Front Immunol"},{"key":"1408_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.844142","volume":"13","author":"B Lv","year":"2022","unstructured":"Lv B, Wang Y, Ma D, Cheng W, Liu J, Yong T, et al. Immunotherapy: reshape the tumor immune microenvironment. Front Immunol. 2022;13:844142. https:\/\/doi.org\/10.3389\/fimmu.2022.844142.","journal-title":"Front Immunol"},{"issue":"1","key":"1408_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01428-1","volume":"20","author":"X Mao","year":"2021","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131. https:\/\/doi.org\/10.1186\/s12943-021-01428-1.","journal-title":"Mol Cancer"},{"issue":"2","key":"1408_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","volume":"21","author":"SA Lasser","year":"2024","unstructured":"Lasser SA, Ozbay Kurt FG, Arkhypov I, Utikal J, Umansky V. Myeloid-derived suppressor cells in cancer and cancer therapy. Nat Rev Clin Oncol. 2024;21(2):147\u201364. https:\/\/doi.org\/10.1038\/s41571-023-00846-y.","journal-title":"Nat Rev Clin Oncol"},{"issue":"Pt A","key":"1408_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112949","volume":"142","author":"S Rajkumari","year":"2024","unstructured":"Rajkumari S, Singh J, Agrawal U, Agrawal S. Myeloid-derived suppressor cells in cancer: current knowledge and future perspectives. Int Immunopharmacol. 2024;142(Pt A):112949. https:\/\/doi.org\/10.1016\/j.intimp.2024.112949.","journal-title":"Int Immunopharmacol"},{"key":"1408_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154711","volume":"248","author":"L Li","year":"2023","unstructured":"Li L, Li M, Jia Q. Myeloid-derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in cancer. Pathol Res Pract. 2023;248:154711. https:\/\/doi.org\/10.1016\/j.prp.2023.154711.","journal-title":"Pathol Res Pract"},{"key":"1408_CR14","doi-asserted-by":"publisher","first-page":"1611210","DOI":"10.3389\/pore.2023.1611210","volume":"29","author":"W Jiang","year":"2023","unstructured":"Jiang W, Hu K, Liu X, Gao J, Zhu L. Single-cell transcriptome analysis reveals the clinical implications of myeloid-derived suppressor cells in head and neck squamous cell carcinoma. Pathol oncol res: POR. 2023;29:1611210. https:\/\/doi.org\/10.3389\/pore.2023.1611210.","journal-title":"Pathol oncol res: POR"},{"key":"1408_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.989141","volume":"13","author":"GC Wang","year":"2022","unstructured":"Wang GC, Zhou M, Zhang Y, Cai HM, Chiang ST, Chen Q, et al. Screening and identifying a novel M-MDSCs-related gene signature for predicting prognostic risk and immunotherapeutic responses in patients with lung adenocarcinoma. Front Genet. 2022;13:989141. https:\/\/doi.org\/10.3389\/fgene.2022.989141.","journal-title":"Front Genet"},{"key":"1408_CR16","doi-asserted-by":"publisher","first-page":"1021262","DOI":"10.3389\/fonc.2023.1021262","volume":"13","author":"X Pan","year":"2023","unstructured":"Pan X, Xu X, Wang L, Zhang S, Chen Y, Yang R, et al. BASP1 is a prognostic biomarker associated with immunotherapeutic response in head and neck squamous cell carcinoma. Front Oncol. 2023;13:1021262. https:\/\/doi.org\/10.3389\/fonc.2023.1021262.","journal-title":"Front Oncol"},{"issue":"5","key":"1408_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/07357907.2021.1910290","volume":"39","author":"X Wang","year":"2021","unstructured":"Wang X, Cao Y, BoPan B, Meng Q, Yu Y. High BASP1 expression is associated with poor prognosis and promotes tumor progression in human lung adenocarcinoma. Cancer Invest. 2021;39(5):409\u201322. https:\/\/doi.org\/10.1080\/07357907.2021.1910290.","journal-title":"Cancer Invest"},{"issue":"9","key":"1408_CR18","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53(9):1334\u201347. https:\/\/doi.org\/10.1038\/s41588-021-00911-1.","journal-title":"Nat Genet"},{"issue":"5","key":"1408_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"1408_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559.","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"1408_CR21","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1408_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods"},{"issue":"W1","key":"1408_CR23","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314. https:\/\/doi.org\/10.1093\/nar\/gkaa407.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1408_CR24","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","volume":"22","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6):bbab260. https:\/\/doi.org\/10.1093\/bib\/bbab260.","journal-title":"Brief Bioinform"},{"issue":"3","key":"1408_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10549-023-06982-4","volume":"200","author":"L Qian","year":"2023","unstructured":"Qian L, Li L, Li Y, Li S, Zhang B, Zhu Y, et al. LncRNA HOTAIR as a ceRNA is related to breast cancer risk and prognosis. Breast Cancer Res Treat. 2023;200(3):375\u201390. https:\/\/doi.org\/10.1007\/s10549-023-06982-4.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"1408_CR26","doi-asserted-by":"publisher","first-page":"e70789","DOI":"10.1002\/cam4.70789","volume":"14","author":"J Yang","year":"2025","unstructured":"Yang J, Lu H, Li L. Chemokines: Orchestration of the Tumor Microenvironment and Control of Hepatocellular Carcinoma Progression. Cancer Med. 2025;14(7):e70789. https:\/\/doi.org\/10.1002\/cam4.70789.","journal-title":"Cancer Med"},{"issue":"2","key":"1408_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10555-021-09970-6","volume":"40","author":"S Saxena","year":"2021","unstructured":"Saxena S, Singh RK. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity. Cancer Metastasis Rev. 2021;40(2):447\u201376. https:\/\/doi.org\/10.1007\/s10555-021-09970-6.","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"1408_CR28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jhep.2024.09.044","volume":"82","author":"Y Lu","year":"2025","unstructured":"Lu Y, Liu Y, Zuo X, Li G, Wang J, Liu J, et al. CXCL12(+) tumor-associated endothelial cells promote immune resistance in hepatocellular carcinoma. J Hepatol. 2025;82(4):634\u201348. https:\/\/doi.org\/10.1016\/j.jhep.2024.09.044.","journal-title":"J Hepatol"},{"key":"1408_CR29","doi-asserted-by":"publisher","first-page":"8628695","DOI":"10.1155\/2020\/8628695","volume":"2020","author":"L Li","year":"2020","unstructured":"Li L, Meng Q, Li G, Zhao L. BASP1 Suppresses Cell Growth and Metastasis through Inhibiting Wnt\/beta-Catenin Pathway in Gastric Cancer. Biomed Res Int. 2020;2020:8628695. https:\/\/doi.org\/10.1155\/2020\/8628695.","journal-title":"Biomed Res Int"},{"issue":"12","key":"1408_CR30","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.4103\/0366-6999.183434","volume":"129","author":"RS Guo","year":"2016","unstructured":"Guo RS, Yu Y, Chen J, Chen YY, Shen N, Qiu M. Restoration of brain acid soluble protein 1 inhibits proliferation and migration of thyroid cancer cells. Chin Med J. 2016;129(12):1439\u201346. https:\/\/doi.org\/10.4103\/0366-6999.183434.","journal-title":"Chin Med J"},{"issue":"5","key":"1408_CR31","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.asjsur.2021.08.015","volume":"45","author":"Y Li","year":"2022","unstructured":"Li Y, Wu T, Jiao Z, Yang A. BASP1 is up-regulated in tongue squamous cell carcinoma and associated with a poor prognosis. Asian J Surg. 2022;45(5):1101\u20136. https:\/\/doi.org\/10.1016\/j.asjsur.2021.08.015.","journal-title":"Asian J Surg"},{"issue":"11","key":"1408_CR32","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.31557\/APJCP.2020.21.11.3435","volume":"21","author":"A Jaikumarr Ram","year":"2020","unstructured":"Jaikumarr Ram A, Girija As S, Jayaseelan VP, Arumugam P. Overexpression of BASP1 Indicates a poor prognosis in head and neck squamous cell carcinoma. Asian Pacific J cancer prevention: APJCP. 2020;21(11):3435\u20139. https:\/\/doi.org\/10.31557\/APJCP.2020.21.11.3435.","journal-title":"Asian Pacific J cancer prevention: APJCP"},{"key":"1408_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12935-017-0452-4","volume":"17","author":"H Tang","year":"2017","unstructured":"Tang H, Wang Y, Zhang B, Xiong S, Liu L, Chen W, et al. High brain acid soluble protein 1(BASP1) is a poor prognostic factor for cervical cancer and promotes tumor growth. Cancer Cell Int. 2017;17:97. https:\/\/doi.org\/10.1186\/s12935-017-0452-4.","journal-title":"Cancer Cell Int"},{"issue":"24","key":"1408_CR34","doi-asserted-by":"publisher","first-page":"10925","DOI":"10.7150\/thno.49425","volume":"10","author":"CC Lin","year":"2020","unstructured":"Lin CC, Huang YK, Cho CF, Lin YS, Lo CC, Kuo TT, et al. Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression. Theranostics. 2020;10(24):10925\u201339. https:\/\/doi.org\/10.7150\/thno.49425.","journal-title":"Theranostics"},{"issue":"12","key":"1408_CR35","doi-asserted-by":"publisher","first-page":"13538","DOI":"10.1002\/cam4.6037","volume":"12","author":"Q Song","year":"2023","unstructured":"Song Q, Zhang W, Shi D, Zhang Z, Zhao Q, Wang M, et al. Overexpression of cannabinoid receptor 2 is associated with human breast cancer proliferation, apoptosis, chemosensitivity and prognosis via the PI3K\/Akt\/mTOR signaling pathway. Cancer Med. 2023;12(12):13538\u201350. https:\/\/doi.org\/10.1002\/cam4.6037.","journal-title":"Cancer Med"},{"key":"1408_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00400","volume":"9","author":"W Hu","year":"2019","unstructured":"Hu W, Feng CM, Liu LY, Li N, Tian F, Du JX, et al. TIPE1 inhibits breast cancer proliferation by downregulating erk phosphorylation and predicts a favorable prognosis. Front Oncol. 2019;9:400. https:\/\/doi.org\/10.3389\/fonc.2019.00400.","journal-title":"Front Oncol"},{"issue":"5","key":"1408_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.179","volume":"8","author":"LA Marsh","year":"2017","unstructured":"Marsh LA, Carrera S, Shandilya J, Heesom KJ, Davidson AD, Medler KF, et al. BASP1 interacts with oestrogen receptor alpha and modifies the tamoxifen response. Cell Death Dis. 2017;8(5):e2771. https:\/\/doi.org\/10.1038\/cddis.2017.179.","journal-title":"Cell Death Dis"},{"issue":"9","key":"1408_CR38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Shen M, Wu L, Yang H, Yao Y, Yang Q, et al. Stromal cells in the tumor microenvironment: accomplices of tumor progression? Cell Death Dis. 2023;14(9):587. https:\/\/doi.org\/10.1038\/s41419-023-06110-6.","journal-title":"Cell Death Dis"},{"key":"1408_CR39","doi-asserted-by":"publisher","first-page":"655855","DOI":"10.3389\/fgene.2021.655855","volume":"12","author":"J Jia","year":"2021","unstructured":"Jia J, Dai Y, Zhang Q, Tang P, Fu Q, Xiong G. Stromal score-based gene signature: a prognostic prediction model for colon cancer. Front Genet. 2021;12:655855. https:\/\/doi.org\/10.3389\/fgene.2021.655855.","journal-title":"Front Genet"},{"key":"1408_CR40","doi-asserted-by":"publisher","first-page":"107167","DOI":"10.1016\/j.intimp.2020.107167","volume":"90","author":"Q Dai","year":"2021","unstructured":"Dai Q, Wu W, Amei A, Yan X, Lu L, Wang Z. Regulation and characterization of tumor-infiltrating immune cells in breast cancer. Int Immunopharmacol. 2021;90:107167. https:\/\/doi.org\/10.1016\/j.intimp.2020.107167.","journal-title":"Int Immunopharmacol"},{"key":"1408_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40425-016-0165-6","volume":"4","author":"SE Stanton","year":"2016","unstructured":"Stanton SE, Disis ML. Clinical significance of tumor-infiltrating lymphocytes in breast cancer. J Immunother Cancer. 2016;4:59. https:\/\/doi.org\/10.1186\/s40425-016-0165-6.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"1408_CR42","doi-asserted-by":"publisher","first-page":"eadr7934","DOI":"10.1126\/sciadv.adr7934","volume":"11","author":"C Fusco","year":"2025","unstructured":"Fusco C, Di Rella F, Liotti A, Colamatteo A, Ferrara AL, Gigantino V, et al. CD4(+)FOXP3Exon2(+) regulatory T cell frequency predicts breast cancer prognosis and survival. Sci Adv. 2025;11(3):eadr7934. https:\/\/doi.org\/10.1126\/sciadv.adr7934.","journal-title":"Sci Adv"},{"issue":"3","key":"1408_CR43","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ccell.2023.01.004","volume":"41","author":"B Virassamy","year":"2023","unstructured":"Virassamy B, Caramia F, Savas P, Sant S, Wang J, Christo SN, et al. Intratumoral CD8(+) T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer. Cancer Cell. 2023;41(3):585-601 e8. https:\/\/doi.org\/10.1016\/j.ccell.2023.01.004.","journal-title":"Cancer Cell"},{"issue":"1","key":"1408_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/JLB.4RU0819-150RR","volume":"107","author":"MJ Sanaei","year":"2020","unstructured":"Sanaei MJ, Salimzadeh L, Bagheri N. Crosstalk between myeloid-derived suppressor cells and the immune system in prostate cancer: MDSCs and immune system in Prostate cancer. J Leukoc Biol. 2020;107(1):43\u201356. https:\/\/doi.org\/10.1002\/JLB.4RU0819-150RR.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1408_CR45","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12967-026-07766-2","volume":"24","author":"ZH Zhang","year":"2026","unstructured":"Zhang ZH, Yin JZ, Li W, Xiao H, Wang D, Yang MH. Multiomics analysis reveals that senescent CXCL16(+) macrophages promote lung adenocarcinoma progression through TGF-beta signalling. J transla med. 2026;24(1):306. https:\/\/doi.org\/10.1186\/s12967-026-07766-2.","journal-title":"J transla med"},{"issue":"1","key":"1408_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.7150\/ijms.116010","volume":"23","author":"B Zhang","year":"2026","unstructured":"Zhang B, Yuan X, Meng L, Liu Y, Wang Y, Chen Z, et al. Tumor-derived CXCL10 and CCL20 polarize the immune microenvironment in nasopharyngeal carcinoma via competitive recruitment of effector T cells and Tregs. Int J Med Sci. 2026;23(1):26\u201341. https:\/\/doi.org\/10.7150\/ijms.116010.","journal-title":"Int J Med Sci"},{"issue":"5","key":"1408_CR47","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1084\/jem.20170277","volume":"216","author":"M Rapp","year":"2019","unstructured":"Rapp M, Wintergerst MWM, Kunz WG, Vetter VK, Knott MML, Lisowski D, et al. CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes. J Exp Med. 2019;216(5):1170\u201381. https:\/\/doi.org\/10.1084\/jem.20170277.","journal-title":"J Exp Med"},{"issue":"5","key":"1408_CR48","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1189\/jlb.0911465","volume":"92","author":"SM Centuori","year":"2012","unstructured":"Centuori SM, Trad M, LaCasse CJ, Alizadeh D, Larmonier CB, Hanke NT, et al. Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-\u03b2-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25\u2212FoxP3\u2212 T cells. J Leukoc Biol. 2012;92(5):987\u201397. https:\/\/doi.org\/10.1189\/jlb.0911465.","journal-title":"J Leukoc Biol"},{"issue":"12","key":"1408_CR49","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1038\/s42255-022-00676-9","volume":"4","author":"H Zhao","year":"2022","unstructured":"Zhao H, Teng D, Yang L, Xu X, Chen J, Jiang T, et al. Myeloid-derived itaconate suppresses cytotoxic CD8(+) T cells and promotes tumour growth. Nat Metab. 2022;4(12):1660\u201373. https:\/\/doi.org\/10.1038\/s42255-022-00676-9.","journal-title":"Nat Metab"},{"issue":"4","key":"1408_CR50","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.semcancer.2012.01.010","volume":"22","author":"S Nagaraj","year":"2012","unstructured":"Nagaraj S, Gabrilovich DI. Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells. Semin Cancer Biol. 2012;22(4):282\u20138. https:\/\/doi.org\/10.1016\/j.semcancer.2012.01.010.","journal-title":"Semin Cancer Biol"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01408-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01408-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01408-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:35:26Z","timestamp":1782228926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01408-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1408"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01408-x","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethical Committee of Affiliated Hospital of Inner Mongolia Medical University granted approval for the study\u00a0(YJS2024055), and informed consent was acquired from each participant.\u00a0And animal protocols were approved by the Institional Animal Care and Use Committee of Yi Shengyuan Gene Technology (Tianjin) Co., Ltd. (protocol number YSY-DWLL-2025061).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"91"}}